Case 8-2009: A 36-year-old woman with headache, hypertension, and seizure 2 weeks post Partum

New England Journal of Medicine

Volumn 360, Issue 11, 2009, Pages 1126-1137

  Singhal, Aneesh B ^a   Kimberly, W Taylor ^a   Schaefer, Pamela W ^b   Hedley Whyte, E Tessa ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; AUTOPSY; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASCULITIS; BRAIN VASOSPASM; CASE REPORT; CEREBRAL SINUS THROMBOSIS; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE COURSE; ECLAMPSIA; ELECTROENCEPHALOGRAM; FEMALE; GENERAL CONDITION DETERIORATION; HEADACHE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LABORATORY TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTDURAL PUNCTURE HEADACHE; POSTPARTUM ANGIOPATHY; POSTPARTUM ECLAMPSIA; PRIMARY HEADACHE; PRIORITY JOURNAL; PUERPERIUM; SEIZURE; STROKE; SUBARACHNOID HEMORRHAGE; VASCULAR DISEASE; BRAIN; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; FATALITY; PATHOLOGY; PREGNANCY; PUERPERAL DISORDER; RADIOGRAPHY; VASOCONSTRICTION;

ADULT; BRAIN; BRAIN EDEMA; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ECLAMPSIA; FATAL OUTCOME; FEMALE; HEADACHE DISORDERS, PRIMARY; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; PREGNANCY; PUERPERAL DISORDERS; SEIZURES; STROKE; TOMOGRAPHY, X-RAY COMPUTED; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 78650421820     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc0809063     Document Type: Article

References (43)

1. Goldszmidt E, Kern R, Chaput A, Macarthur A. The incidence and etiology of postpartum headaches: a prospective cohort study. Can J Anaesth 2005;52:971-7.
2. Stella CL, Jodicke CD, How HY, Harkness UP, Sibai BM. Postpartum headache: is your work-up complete? Am J Obstet Gynecol 2007;196(4):318.e1-318. e7.
3. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24:Suppl 1:9-160.
4. Schwedt TJ, Matharu MS, Dodick DW. Thunderclap headache. Lancet Neurol 2006;5:621-31.
5. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007;369:306-18.
6. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000;31:1274-82.
7. de Bruijn SF, Stam J, Kappelle LJ. Thunderclap headache as first symptom of cerebral venous sinus thrombosis. Lancet 1996;348:1623-5.
8. Mitsias P, Ramadan NM. Headache in ischemic cerebrovascular disease. I. Clinical features. Cephalalgia 1992:12:269-74.
9. Schievink WI, Wijdicks EF, Meyer FB, Sonntag VK. Spontaneous intracranial hypotension mimicking aneurysmal subarachnoid hemorrhage. Neurosurgery 2001;48:513-7.
10. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
11. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008;65:205-10.
12. Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol 2004;190:1464-6.
13. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005;105:402-10.
14. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005;106:509-16.
15. Calabrese LH, Duna GF, Lie JT. Vasculitis in the central nervous system. Arthritis Rheum 1997;40:1189-201.
16. Salvarani C, Brown RD Jr, Calamia KT, et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007;62:442-51.
17. Duna GF, Calabrese LH. Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 1995;22:662-7.
18. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007;146:34-44.
19. Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke 1988;19:1159-70.
20. Hajj-Ali RA, Furlan A, Abou-Chebel A, Calabrese LH. Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup. Arthritis Rheum 2002;47:662-9.
21. Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 2002;58:130-3.
22. Singhal AB. Cerebral vasoconstriction syndromes. Top Stroke Rehabil 2004;11:1-6.
23. Singhal AB, Bernstein RA. Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocrit Care 2005;3:91-7.
24. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome: a prospective series of 67 patients. Brain 2007;130:3091-101.
25. Chen SP, Fuh JL, Chang FC, Lirng JF, Shia BC, Wang SJ. Transcranial color Doppler study for reversible cerebral vasoconstriction syndromes. Ann Neurol 2008; 63:751-7.
26. Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol 2004;61:411-6.
27. Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2008;29:447-55.
28. Buckie RM, Duboulay G, Smith B. Death due to cerebral vasospasm. J Neurol Neurosurg Psychiatry 1964;27:440-4.
29. Williams TL, Lukovits TG, Harris BT, Harker Rhodes C. A fatal case of postpartum cerebral angiopathy with literature review. Arch Gynecol Obstet 2007;275:67-77.
30. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83.
31. Rana S, Karumanchi SA, Levine RJ, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007;50:137-42.
32. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992-1005. [Erratum, N Engl Med 2006;355:1840.]
33. Hirshfeld-Cytron J, Lam C, Karumanchi SA, Lindheimer M. Late postpartum eclampsia: examples and review. Obstet Gynecol Surv 2006;61:471-80.
34. Koga K, Osuga Y, Yoshino O, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003;88:2348-51.
35. Wikström AK, Larsson A, Eriksson UJ, Nash P, Nordén-Lindeberg S, Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol 2007;109:1368-74.
36. Levine RJ, Thadhani R, Qian C, et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005;293:77-85.
37. Okamoto T, Niu R, Mizutani S, Yamada S. Levels of placenta growth factor in gestational trophoblastic diseases. Am J Obstet Gynecol 2003;188:135-40.
38. Autiero M, Luttun A, Tjwa M, Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 2003;1:1356-70.
39. Maynard SE, Mill JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.
40. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642-9. [Erratum, Nat Med 2006;12:862.]
41. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006;354:980-2.
42. Yang JC, Haworth L, Sherry RM, et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 2003;349:427-34.
43. Calabrese LH, Molloy ES, Singhal AB. Primary central nervous system vasculitis: progress and questions. Ann Neurol 2007;62:430-2.